WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s stock price gapped up prior to trading on Wednesday. The stock had previously closed at $11.25, but opened at $12.30. WuXi Biologics (Cayman) shares last traded at $12.6120, with a volume of 7,558 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One research analyst has rated the stock with a Hold rating. According to data from MarketBeat, the company currently has a consensus rating of “Hold”.
Check Out Our Latest Stock Report on WXXWY
WuXi Biologics (Cayman) Price Performance
The business’s 50-day moving average price is $12.81 and its two-hundred day moving average price is $10.21.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology companies to support the discovery, development and commercial manufacturing of therapies, helping customers advance drug candidates from early research through clinical and commercial production.
Its capabilities include antibody and recombinant protein development, cell-line development, process development, clinical trial material production and large-scale biomanufacturing.
Read More
- Five stocks we like better than WuXi Biologics (Cayman)
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
- Washington Made a $2 Billion Quantum Bet, But Can Either ETF Match It?
- Bloom Energy: The Off-Grid Answer to AI’s Power Drain
- Space Race 2.0: Intuitive Machines Secures Another NASA Contract
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
